Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation

Cited by papers we hold 6

• Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response · 2022
  No notice
• Base-edited CAR T cells for combinational therapy against T cell malignancies · 2021
  No notice
• Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy · 2020
  No notice
• Gene modification strategies for next-generation CAR T cells against solid cancers · 2020
  No notice
• BCMA-targeted immunotherapy for multiple myeloma · 2020
  No notice
• Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.